The focus of the 2019 Gordon Conference on Antimicrobial Peptides is utilizing our knowledge of mechanisms of AMP action, and mining species diversity to advance application to global infection challenges, including the threat of antimicrobial resistance, and sharing experience of translating fundamental research to commercial development and clinical practice.

Akthelia is strongly represented at this conference:

• Birgitta Agerberth, co-founder, has a með Keynote talk titled ""From the Discovery of the Cathelicidin LL-37 to Host-Directed Therapy Fighting Infections"
  
• Guðmundur Hrafn Guðmundsson, co-founder, is a discussion leader in a session on "Exploiting Mechanistic Knowledge to Utilize Immunomodulatory Activities"
  
• Rubhana Raqib from the International Centre for Diarrhoeal Disease Research, a long-time collaborator of Akthelia's founders has a presentation on "Induction of Antimicrobial Host Defense Peptides as a Therapeutic Strategy Against Tuberculosis"
  
• And finally, Iwona T. Myszor from the Biomedical Center at the University of Iceland has a poster presentation showing how Akthelia's compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity

More information about the conference here.